In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide.

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• Immunotherapy has shown promise in cancer treatment, but limited patient responses necessitate predictive biomarkers.
• Understanding the tumor microenvironment, including immune cell phenotype and spatial distribution, is crucial for predicting treatment efficacy.
• Current methods for analyzing tumor tissue complexity are often limited or resource-intensive.

Purpose of the Study:

• To develop a novel, sample-sparing, highly multiplexed immunohistochemistry (mIHC) technique for detailed analysis of the tumor immune microenvironment.
• To create an automated digital solution for analyzing high-dimensional mIHC data, making complex analyses more accessible.
• To enable comprehensive assessment of tissue-based biomarkers for cancer prognosis and therapy response.

Main Methods:

• Developed an iterative mIHC assay involving sequential tagging, imaging, and destaining on a single slide.
• Integrated the mIHC assay with a new automated digital landscaping solution for data analysis.
• Validated the technique for capturing the complexity of the tumor immunome using standard pathology workflows.

Main Results:

• The developed mIHC technique allows for high-dimensional analysis of tumor tissues while preserving samples.
• The automated digital solution simplifies and democratizes access to complex immunome profiling.
• The method successfully captures the intricate spatial and phenotypic information of immune cells within the tumor microenvironment.

Conclusions:

• This innovative mIHC approach provides a powerful tool for advancing cancer immunotherapy research and clinical practice.
• The technique facilitates the discovery and validation of prognostic and predictive biomarkers.
• It offers a versatile platform for in situ monitoring of therapeutic effects and identification of novel disease targets.